Jufeng Wang
Zhengzhou University(CN)Henan Cancer Hospital(CN)Anyang Tumor Hospital(CN)Nanjing University of Aeronautics and Astronautics(CN)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Hepatocellular Carcinoma Treatment and Prognosis, Esophageal Cancer Research and Treatment, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial(2021)391 cited
- → Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis(2000)294 cited
- → Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial(2024)211 cited
- → Human SERCA2a levels correlate inversely with age in senescent human myocardium(1998)127 cited
- → The Metabolic and Cardiovascular Effects of Hyperthyroidism Are Largely Independent of β-Adrenergic Stimulation(2004)61 cited
- → Cardiac Dysfunction Caused by Myocardium-Specific Expression of a Mutant Thyroid Hormone Receptor(2000)46 cited